Back to Agenda
Session 18: The FDA and Risk Management
Session Chair(s)
Michael Hamrell, PhD, RAC
President
MORIAH Consultants, United States
- Premarketing risk assessment
- Postmarketing risk assessment
- Risk evaluation and mitigation strategies
Have an account?